Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
As-needed Symbicort versus terbutaline or maintenance Pulmicort in adolescents and adults with asthma
2013-004474-96Phase 3Completed
- Sponsor
- AstraZeneca
- Start
- Mar 2014
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of budesonide and terbutaline in asthma (3 arms), sponsored by AstraZeneca. Primary endpoint: Well-controlled asthma weeks. Started Mar 2014; status: completed.
02
Drugs
budesonideterbutaline
03
Conditions
asthma
Beyond the preview
Go deeper on 2013-004474-96.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2013-004474-96.